Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameHke Holdings
Stock Code01726
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities以新加坡為基地的醫療保健行業專業承建商,具備輻射防護工程專業知識,主要為新加坡的醫院及診所提供綜合設計及建築服務,亦從事維護及其他服務以及工具及材料銷售。
Listing Date2018-04-18
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港干諾道中168-200號信德中心招商局大廈24樓2414-2416室
Business Address (Hong Kong)香港中環花園道3號中國工商銀行大廈16樓1604-6室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehwakoon.com
Share Registrar宝德隆
Registrar Contact(852)2153 1688
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 0.55 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueRMB 0.01 / shares
Offer Period2018-03-28 to 2018-04-04
Global Offering Shares200,000,000 shares
HK Public Offer Shares (Initial)20,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)180,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO800,000,000 shares
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 110,000,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 757.8M
Est. Threshold HK$ 9.73B
Analysis Result HK market cap below threshold, need +1184%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約5.2百萬新加坡元
Period-End Cash Balance新加坡元4.0百萬元
Listing Expenses~HK$ 26,000,000
Listing Expenses / Funds Raised~23.64%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: RMB
Income Statement
Item 2015-062016-062017-062017-09
Revenue 13,244,5039,793,08314,937,4184,034,961
Cost of sales -7,971,327-6,187,490-8,432,129-2,258,059
Gross profit 5,273,1763,605,5936,505,2891,776,902
Other income and gains, net 23,16050,63948,4688,201
Administrative expenses -1,173,671-634,716-618,196-177,699
Net finance costs -2,327-22500
Profit before tax 4,120,3383,021,2916,068,386-191,155
Income tax expense -653,575-340,367-917,764-247,831
Profit for the year 3,466,7632,680,9245,150,622-438,986
Balance Sheet
Item 2015-062016-062017-062017-09
Cash and cash equivalents 3,751,8351,095,4344,011,2693,939,661
Trade and bills receivables 1,968,8022,322,1593,477,8654,334,638
Total current assets 6,129,2626,853,8259,759,18311,843,571
Total assets 6,791,6417,539,34810,505,97912,565,905
Total current liabilities 3,193,6732,654,0592,365,2324,865,356
Total liabilities 3,208,0922,670,6872,390,8844,889,660
Total equity 3,583,5494,868,6618,115,0957,676,245
Equity attributable to owners 3,583,5494,868,6618,115,0957,676,245
Interest-bearing borrowings 15,777000
Cash Flow Statement
Item 2015-062016-062017-062017-09
Net cash from operating activities 3,481,9511,563,5273,683,923105,814
Net cash from investing activities -3,993-2,056,5471,952,882-177,558
Net cash from financing activities -1,468,774-2,163,381-2,720,970136
Net increase in cash 2,009,184-2,656,4012,915,835-71,608
Depreciation of PP&E 78,27176,25398,58229,531
Purchase of PP&E -3,993-99,397-159,855-5,069
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 0.56
First Day OpenHK$ 0.7
First Day Change1.82%
First Day Volume289780000.0
First Day Turnover179169000.0
Use of Proceeds
1、約38.6百萬港元,約45.9%,用于在截至2019年6月30日止年度前購置建筑面積約900至1,000平方呎、作工場及辦公室用途的額外物業,以(a)應對人力擴充計劃;及(b)獲得更多制造輻射防護產品的空間; 2、約24.4百萬港元,約29.1%,用于通過招募更多員工擴充人力,以(a)減少我們對分包服務的需求及由此產生的相關費用;及(b)增加我們內部承接更多綜合設計及建筑服務項目的能力; 3、約5.5百萬港元,約6.5%,用于增加我們就出具以我們的客戶為受益人的履約保函提供資金的儲備金; 4、約5.8百萬港元,約6.9%,用于購置(a)額外汽車,以應對我們運輸需求的增加;及(b)額外機械,以進行起重及木工工程; 5、約2.6百萬港元(相當于約0.4百萬新加坡元),約3.1%,用于通過宣傳我們在新加坡醫療相關建筑行業的品牌知名度及市場形象加大市場推廣力度; 6、約7.1百萬港元(相當于約1.1百萬新加坡元),約8.5%,用作一般營運資金。

Underwriting Syndicate

Sole Sponsor (1)
Dakin Capital Limited CE BGC821
Joint Bookrunners (1)
HEAD & SHOULDERS SECURITIES LIMITED CE AFS455
Joint Lead Managers (1)
HEAD & SHOULDERS SECURITIES LIMITED CE AFS455

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman洪坤明—
Company Secretary鄭家穗—
No director data available.

Major Shareholders

Major Shareholders & Holdings控股股東洪先生、王先生及許先生作為一組一致行動的控股股東,透過Skylight Illumination間接持有本公司合共75%權益(600,000,000股)。
About this page

This page shows Hke Holdings (01726) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect